Clinical trial

Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial

NCT00059332 · Jeffrey L. Saver, Other · Completed

Key facts

NCT number NCT00059332
Title Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial
Official title Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field
Acronym FAST-MAG
Lead sponsor Jeffrey L. Saver, Other
Collaborators National Institute of Neurological Disorders and Stroke (NINDS) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cerebrovascular Accident
Intervention type Drug
Interventions Magnesium Sulfate, Normal Saline
Enrollment 1,700
Start date Jan 1, 2005
Primary completion Mar 1, 2013
Completion Mar 1, 2013
First posted Apr 24, 2003
Last update posted Aug 21, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies